Peter Thuss‐Patience
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment 55
- Pulmonary and Respiratory Medicine top 0.5%
- Gastric Cancer Management and Outcomes 127
- Metastasis and carcinoma case studies 17
- Oncology top 1%
- Colorectal Cancer Treatments and Studies 44
- Cancer Immunotherapy and Biomarkers 26
- HER2/EGFR in Cancer Research 18
- Pancreatic and Hepatic Oncology Research 15
- Surgery top 2%
- Esophageal Cancer Research and Treatment 64
- Obstetrics and Gynecology top 5%
- Co-authors
- Peter ReichardtAlbrecht KretzschmarGuido SchumacherDmitry BichevSylvie LorenzenDaniel PinkFlorian LordickAxel Hinke
- Journals
- Journal of Clinical Oncology (54 papers)Annals of Oncology (26 papers)European Journal of Cancer (11 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Peter Thuss‐Patience
166 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Gastroenterology 927
- Pulmonary and Respiratory Medicine 2.9k
- Oncology 2.2k
- Surgery 1.7k
- Obstetrics and Gynecology 129
Countries citing papers authored by Peter Thuss‐Patience
This map shows the geographic impact of Peter Thuss‐Patience's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Thuss‐Patience with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Thuss‐Patience more than expected).
Fields of papers citing papers by Peter Thuss‐Patience
This network shows the impact of papers produced by Peter Thuss‐Patience. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Thuss‐Patience. The network helps show where Peter Thuss‐Patience may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Thuss‐Patience, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 13 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 13 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 26 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 9 | |
| 14 | 2021 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2017 | 38 | |
| 17 | Trastuzumab emtansine versus taxane use for previously treated HER2-positive locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GATSBY): an international randomised, open-label, adaptive, phase 2/3 studybreakdown → | 2017 | 391 |
| 18 | 2017 | 20 | |
| 19 | 2016 | 0 | |
| 20 | 2003 | 202 |
About Peter Thuss‐Patience
Peter Thuss‐Patience is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Oncology, having authored 178 papers that have together received 4.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (127 papers), Esophageal Cancer Research and Treatment (64 papers), Gastrointestinal Tumor Research and Treatment (55 papers), Colorectal Cancer Treatments and Studies (44 papers), Cancer Immunotherapy and Biomarkers (26 papers), HER2/EGFR in Cancer Research (18 papers), Metastasis and carcinoma case studies (17 papers) and Pancreatic and Hepatic Oncology Research (15 papers). The work is most often cited by research in Gastroenterology (927 citations), Pulmonary and Respiratory Medicine (2.9k citations) and Oncology (2.2k citations). Peter Thuss‐Patience has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Peter Reichardt, Albrecht Kretzschmar, Guido Schumacher, Dmitry Bichev, Sylvie Lorenzen, Daniel Pink, Florian Lordick, Axel Hinke, Kirstin Breithaupt and Eric Van Cutsem. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Gastric Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.